| Tag | Content |
|---|
EnhancerAtlas ID | HS196-01722 |
Organism | Homo sapiens |
Tissue/cell | ZR75-1 |
Coordinate | chr1:120666190-120667040 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| POU4F2 | MA0683.1 | chr1:120666259-120666275 | TTGCATAATAAATTAT | + | 6.44 |
|
| | Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
| SE_09137 | chr1:120657976-120676855 | CD14 | | SE_10518 | chr1:120663764-120667960 | CD19_Primary | | SE_30199 | chr1:120664402-120667164 | Fetal_Muscle | | SE_37175 | chr1:120665860-120667844 | HSMMtube | | SE_43507 | chr1:120649245-120667929 | MM1S | | SE_45569 | chr1:120652986-120668944 | Osteoblasts | | SE_55738 | chr1:120664236-120667847 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I120121 | chr1 | 120664371 | 120666999 |
|
Enhancer Sequence | TATGTCATTA TTAAACTGAC ACTCAGTGTT TATATTACTA TGATCAAATA AATACTATTC 60
ACACCTGTGT TGCATAATAA ATTATGATCA CTTTCTTCAA AACTATTTTG CTTCCTCTGG 120
AGTTAATAAT TGTCTCATTT TTCATTTGCC TAGTTTTTCT ATGCATATGC CACTAATTTA 180
ATCCATACTC CTCTGTAGTT GTTTAAGTCT CCTCTCAATA TGTCCAAACA AACTTGGTAT 240
TCCATCAGTT TCATCTGGAA GAGAGCTCTT CCAGAGCCTA CTGATCTGCT CCTCTCTGGG 300
CTAACTGACC TCTAGGCCTG CTGTGCATCT GTCATCTTGG GACTTCCCTT TACCCACATC 360
CTGGGGACTC TCTTCACCTC TGTGTTGAGT GCTCTGGTTC CTGAATTCCA CCTCTTCCTC 420
TTTCTTGACT CACAACACTG TTTTGGTGGA GCACATTCTT CAGTAGTTTC CTAAGAGAGA 480
GTGCAGGGAA GATATAGCAT TTGCCATCAG TGCCCTGCCC AAATTCTCTT GGCACTTAAC 540
ATCCAGGCCT TCAAAACTGC CAGCACATAT GTCTGTTTGC CTGAGGGCTT TTTCTAGCTA 600
CTGAAAGTTT GCTCAGGAAG TGTTGGGGAA TTAACCCCCT TTTCCCTGGG AGAGACCCTT 660
AACCAATGAC TGATGAGAGT TAGTAGATAA ATATCCCAGC TTGCTCAACC ATGAGGGGGT 720
TTAACCCTGA AGCATGCTTT CTACACAGGT CTCCCAGAGT TCCCCGATGG AGTCAAGTTC 780
CACTGGTTCA CAGTAACTTG CAAGATATAT TAACTTCCGT AGGATCCTTT TCTCGTTACT 840
TTACTCCCGT 850
|
